liver cancer - Leading Justice

Valsartan Lawsuit MDL: Latest Updates on Cancer-Related Claims

Product Liability / July 24, 2024 / 4 minutes of reading / By Faith Anderson / Bladder Cancer, blood pressure, Cancer, colorectal cancer, drug injury, drug injury lawsuit, esophageal cancer, high blood pressure, intestinal cancer, liver cancer, NDEA, NDMA, product liability lawsuit, prostate cancer, side effects, stomach cancer, valsartan, valsartan MDL, valsartan recall, valsartan settlement, valsartan update

Lawsuits over the alleged link between valsartan and cancer have raised serious concerns about the safety of this widely prescribed blood pressure medication. Reports of contamination with N-nitrosodimethylamine (NDMA), a potential carcinogen, have led to widespread recalls and a surge in legal claims. Patients who relied on valsartan, an angiotensin II receptor blocker (ARB), now […]

Valsartan Lawsuit MDL: Latest Updates on Cancer-Related Claims Read More »

Settlement Nearing for Valsartan Plaintiffs Suing Hetero, But Fight Continues Against Other Manufacturers

Product Liability / June 24, 2024 / 3 minutes of reading / By Faith Anderson / Bladder Cancer, blood pressure, Cancer, colorectal cancer, drug injury, drug injury lawsuit, esophageal cancer, high blood pressure, intestinal cancer, liver cancer, NDEA, NDMA, prostate cancer, side effects, stomach cancer, valsartan, valsartan recall, valsartan settlement

In a notable development in the ongoing valsartan litigation, lawyers are nearing a settlement agreement for those who sued Hetero, a manufacturer of the generic blood pressure medication that was tainted with carcinogenic impurities. This settlement, overseen by U.S. District Court Judge Renée M. Bumb in New Jersey, aims to provide relief to a subset

Settlement Nearing for Valsartan Plaintiffs Suing Hetero, But Fight Continues Against Other Manufacturers Read More »

Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims

Product Liability / June 13, 2024 / 4 minutes of reading / By Faith Anderson / Bladder Cancer, blood pressure, Cancer, colorectal cancer, drug injury, drug injury lawsuit, esophageal cancer, high blood pressure, intestinal cancer, liver cancer, NDMA, prostate cancer, settlement, settlement agreement, side effects, stomach cancer, valsartan, valsartan recall, valsartan settlement

One of the key players involved in the ongoing valsartan NDMA litigation has agreed to a settlement of valsartan lawsuits, providing some relief to individuals impacted by the contaminated blood pressure medication. The U.S. District Judge presiding over the valsartan lawsuits has been informed that a preliminary settlement agreement has been reached with Hetero Drugs,

Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims Read More »

First Valsartan NDMA Cancer Lawsuit Cleared to Proceed to Trial

Product Liability / April 12, 2024 / 4 minutes of reading / By Faith Anderson / Bladder Cancer, blood pressure, Cancer, colorectal cancer, drug injury, drug injury lawsuit, esophageal cancer, high blood pressure, intestinal cancer, liver cancer, NDMA, prostate cancer, side effects, stomach cancer, valsartan, valsartan recall

More than five years after the initial valsartan recalls, the U.S. District Judge overseeing the valsartan litigation has greenlit the first trial against manufacturers and distributors of the tainted generic blood pressure drug. Over 1,200 valsartan lawsuits have been filed, with individuals alleging that changes to the manufacturing process resulted in the distribution of valsartan

First Valsartan NDMA Cancer Lawsuit Cleared to Proceed to Trial Read More »

Valsartan

Product Liability / April 12, 2024 / 11 minutes of reading / By Faith Anderson / angiotensin II receptor blocker, ARB, Bladder Cancer, blood pressure, blood pressure drug, Cancer, cancer lawsuit, colorectal cancer, Heart Failure, high blood pressure, kidney cancer, liver cancer, stomach cancer, valsartan

Did You Develop Cancer After Taking Valsartan? Valsartan, a commonly prescribed blood pressure medication, has been associated with potential side effects such as an increased risk of cancer, including liver, kidney, and digestive tract cancers, due to the presence of NDMA and other cancer-causing impurities in some batches of the drug. Start My Valsartan Cancer

Valsartan Read More »

Zantac Cancer Lawsuit: Settlement Reached in 4,000 Claims Involving Recalled Heartburn Drug

Product Liability / April 8, 2024 / 4 minutes of reading / By Faith Anderson / Bladder Cancer, Cancer, drug injury, drug injury lawsuit, liver cancer, pancreatic cancer, ranitidine, settlement, settlement agreement, side effects, stomach cancer, zantac, zantac cancer lawsuit, zantac lawsuit, zantac recall

Sanofi, the pharmaceutical company behind Zantac (ranitidine), has recently announced a significant settlement agreement to resolve approximately 4,000 cancer lawsuits filed in state courts across the United States. Although this settlement marks a step towards resolution, Sanofi still faces tens of thousands of pending claims related to the recalled heartburn drug, the majority of them

Zantac Cancer Lawsuit: Settlement Reached in 4,000 Claims Involving Recalled Heartburn Drug Read More »

Camp Lejeune

Personal Injury / October 4, 2023 / 13 minutes of reading / By Faith Anderson / aplastic anemia, birth defect, Bladder Cancer, camp lejeune, cancer lawsuit, contaminated drinking water, kidney cancer, liver cancer, military base, non-hodgkin's lymphoma, parkinson's disease, toxic chemicals, water contamination

Did You Develop Cancer from the Water at Camp Lejeune? A new law makes it easier for victims exposed to contaminated water at Marine Corps Base Camp Lejeune to sue the U.S. government for illnesses and injuries they have suffered, including cancer, birth defects, Parkinson’s disease, and wrongful death. Start My Camp Lejeune Claim Now

Camp Lejeune Read More »

Get A Free Consultation

Personal Injury Lawsuits

Lawsuit Consultation